GlassScriptPhysician profile
Marek A Martynowicz
NPI 1962581249
$11,578.08
in general payments reported to CMS, 2019-2025
17 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,552 · 2020: $460 · 2021: $289 · 2022: $8,597 · 2023: $158 · 2024: $314 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $646.58 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,509.82 | 2021-2022 | |
| Veran Medical Technologies, INC. | $1,249.76 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $699.55 | 2020-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $539.74 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Pfizer INC. | $127.65 | 2019-2020 | |
| Insmed, INC. | $84.94 | 2019-2024 | Arikayce |
| Genzyme Corporation | $71.24 | 2021-2024 | |
| Amgen INC. | $66.67 | 2021-2025 | |
| United Therapeutics Corporation | $37.24 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.31 | 2020 | |
| Olympus America INC. | $32.50 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $31.68 | 2024 | Dupixent |
| Merck Sharp & Dohme LLC | $25.48 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $22.32 | 2024 | Camzyos |
| Seagen INC. | $21.49 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.00 | 2019 | |
| Eisai INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marek Martynowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.